VANCOUVER, Jan. 25, 2017 /CNW/ - Alternate Health Corp. (the "Company") wishes to expand on its previously announced transdermal patch and sublingual dissolvable tablet delivery systems being licensed under its Medipatch and Sentar agreements. These patented delivery systems represent a safe and controlled method for delivering measured doses of pharmaceutical grade CBD and THC based medicines. The Medipatch and Sentar Agreements are expected to close in the next two weeks.
While terms of the Agreements provide for long-term product development and commercialization, the immediate opportunity to manufacture and distribute proprietary products in the US, Canada and the United Kingdom represent significant revenue generating businesses for Alternate Health for many years to come."These patents allow Alternate Health to specifically control dosages and provide a safe, medically viable delivery system for cannabis and CBD's," said Jim Griffiths, CFO for Alternate Health. "This furthers the Company's plans to become an international leader in cannabis derived medicines."
Under the previously announced pending Alturas Joint Venture Agreement, an existing building on sovereign Native American land in northern California will be used as a research and testing facility. It will also include a CBD extraction and refinement plant expected to be operational this spring. Alternate Health is also currently in discussions with several Canadian LP's (licensed providers) for manufacturing and delivering its patented products and delivery systems in the Canadian market.
According to USA Today, the California marijuana Industry is estimated to grow to $25 billion annually, and is set to eclipse $50 billion by 2026. "Alternate Health is uniquely positioned for licensing their manufacturing pharmaceutical grade delivery systems of CBD and THC healing products in this fast-growing new marketplace," said Jim Tykoliz, Director of New Ventures, Alternate Health. "It is Alternate Health's intentions to provide organic, safe and healthy medicines through our patented delivery systems to patients around the world, and the California market represents a significant starting point for us."
Successful First Day of Trading
On January 24th, 2017, the Company's first day of trading on the Canadian Securities Exchange, Alternate Health's shares opened at $3.28, traded at a high of $3.50, at a low of $3.15, and closed at $3.28; on volume of 44,300 shares.
About Alternate Health
Alternate Health (http://www.alternatehealth.ca) is a diversified healthcare company that uses its expertise in technology to revolutionize patient care and service delivery in both traditional and complementary medical fields. With investments in research, education and cutting edge technology, Alternate Health is a leader in software applications and processing systems for the medical industry using proprietary technology platforms. Through its subsidiaries, Alternate Health offers services ranging from medical practice and controlled substance management software to blood analysis and toxicology labs, to clinical research and continuing education programs. Alternate Health's goal is to continue to lead the medical industry with data-driven results in patient care and product development.
On behalf of the Board of Directors of
ALTERNATE HEALTH CORP.
Director and CFO
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
Statements included in this announcement, including statements concerning our plans, intentions and expectations, which are not historical in nature are intended to be, and are hereby identified as "forward-looking statements". Forward-looking statements may be identified by words including "anticipates", "believes", "intends", "estimates", "expects" and similar expressions. The Company cautions readers that forward-looking statements, including without limitation those relating to the Company's future operations, business prospects and financing plans, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the forward- looking statements.
SOURCE Alternate Health Corp.
To view this news release in HTML formatting, please use the following URL: http://www.newswire.ca/en/releases/archive/January2017/25/c3163.html
For further information: contact Jim Griffiths at 416-607-5757.